Radotinib
Radotinib, and sometimes referred to by its investigational name IY5511, is a drug for the treatment of different types of Y, most notably Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) with resistance or intolerance of other tyrosine kinase Bcr-Abl inhibitors.
Product Specifications
CAS Number
926037-48-1
Product Name Alternative
IY-5511
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
DMSO: 10 mM
Smiles
CC1=CN (C=N1) C1=CC (NC (=O) C2=CC (NC3=NC=CC (=N3) C3=NC=CN=C3) =C (C) C=C2) =CC (=C1) C (F) (F) F
Molecular Formula
C27H21F3N8O
Molecular Weight
530.5
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![MEK1 (MAP2K1) Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI4H8]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
TA505766BM 100 µL
MEK1 (MAP2K1) Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI4H8]
Sign In for Pricing
View Details 